Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 293

1.

Bringing closure: towards achieving a better understanding of Israel.

Rosenstock J, Zimmet P, Skyler JS, Atkinson M, Schatz D, Buse JB, Kahn S, Hirsch IB, Leroith D, Alberti KG.

Lancet. 2019 Jul 31. pii: S0140-6736(19)31760-X. doi: 10.1016/S0140-6736(19)31760-X. [Epub ahead of print] No abstract available.

PMID:
31376991
2.

What is innovation in the area of medicines? The example of insulin and diabetes.

Beran D, Hirsch IB, Yudkin JS.

Diabet Med. 2019 Jul 30. doi: 10.1111/dme.14080. [Epub ahead of print] No abstract available.

PMID:
31361047
3.

Associations between HbA1c and continuous glucose monitoring-derived glycaemic variables.

Hirsch IB, Welsh JB, Calhoun P, Puhr S, Walker TC, Price DA.

Diabet Med. 2019 Jul 3. doi: 10.1111/dme.14065. [Epub ahead of print]

PMID:
31267573
4.

Preventing Early Renal Loss in Diabetes (PERL) Study: A Randomized Double-Blinded Trial of Allopurinol-Rationale, Design, and Baseline Data.

Afkarian M, Polsky S, Parsa A, Aronson R, Caramori ML, Cherney DZ, Crandall JP, de Boer IH, Elliott TG, Galecki AT, Goldfine AB, Haw JS, Hirsch IB, Karger AB, Lingvay I, Maahs DM, McGill JB, Molitch ME, Perkins BA, Pop-Busui R, Pragnell M, Rosas SE, Rossing P, Senior P, Sigal RJ, Spino C, Tuttle KR, Umpierrez GE, Wallia A, Weinstock RS, Wu C, Mauer M, Doria A; PERL Study Group.

Diabetes Care. 2019 Aug;42(8):1454-1463. doi: 10.2337/dc19-0342. Epub 2019 Jun 11.

PMID:
31186299
5.

Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range.

Battelino T, Danne T, Bergenstal RM, Amiel SA, Beck R, Biester T, Bosi E, Buckingham BA, Cefalu WT, Close KL, Cobelli C, Dassau E, DeVries JH, Donaghue KC, Dovc K, Doyle FJ 3rd, Garg S, Grunberger G, Heller S, Heinemann L, Hirsch IB, Hovorka R, Jia W, Kordonouri O, Kovatchev B, Kowalski A, Laffel L, Levine B, Mayorov A, Mathieu C, Murphy HR, Nimri R, Nørgaard K, Parkin CG, Renard E, Rodbard D, Saboo B, Schatz D, Stoner K, Urakami T, Weinzimer SA, Phillip M.

Diabetes Care. 2019 Aug;42(8):1593-1603. doi: 10.2337/dci19-0028. Epub 2019 Jun 8. Review.

6.

Using Flash Continuous Glucose Monitoring in Primary Practice.

Hirsch IB, Wright EE Jr.

Clin Diabetes. 2019 Apr;37(2):150-161. doi: 10.2337/cd18-0054.

PMID:
31057221
7.

Evidence supports prediabetes treatment.

Neumiller JJ, Kalyani RR, Herman WH, Grant RW, Wysham CH, Inzucchi SE, Hirsch IB, Fonseca VA, Buse JB, Barrett EJ.

Science. 2019 Apr 26;364(6438):341-342. doi: 10.1126/science.aax3548. No abstract available.

PMID:
31023917
8.

Effect of liraglutide on anthropometric measurements, sagittal abdominal diameter and adiponectin levels in people with type 2 diabetes treated with multiple daily insulin injections: evaluations from a randomized trial (MDI-liraglutide study 5).

Ahmadi SS, Filipsson K, Dimenäs H, Isaksson SS, Imberg H, Sjöberg S, Ahrén B, Dahlqvist S, Gustafsson T, Tuomilehto J, Hirsch IB, Lind M.

Obes Sci Pract. 2019 Mar 18;5(2):130-140. doi: 10.1002/osp4.324. eCollection 2019 Apr.

9.

Hypoglycemia in People with Type 2 Diabetes and CKD.

Ahmad I, Zelnick LR, Batacchi Z, Robinson N, Dighe A, Manski-Nankervis JE, Furler J, O'Neal DN, Little R, Trence D, Hirsch IB, Bansal N, de Boer IH.

Clin J Am Soc Nephrol. 2019 Jun 7;14(6):844-853. doi: 10.2215/CJN.11650918. Epub 2019 Apr 17.

PMID:
30996047
10.

The Future of the GLP-1 Receptor Agonists.

Hirsch IB.

JAMA. 2019 Apr 16;321(15):1457-1458. doi: 10.1001/jama.2019.2941. No abstract available.

PMID:
30903797
11.

Treatment of Diabetes in Older Adults: An Endocrine Society* Clinical Practice Guideline.

LeRoith D, Biessels GJ, Braithwaite SS, Casanueva FF, Draznin B, Halter JB, Hirsch IB, McDonnell ME, Molitch ME, Murad MH, Sinclair AJ.

J Clin Endocrinol Metab. 2019 May 1;104(5):1520-1574. doi: 10.1210/jc.2019-00198.

PMID:
30903688
12.

Rates of Cardiac Rhythm Abnormalities in Patients with CKD and Diabetes.

Akoum N, Zelnick LR, de Boer IH, Hirsch IB, Trence D, Henry C, Robinson N, Bansal N.

Clin J Am Soc Nephrol. 2019 Apr 5;14(4):549-556. doi: 10.2215/CJN.09420818. Epub 2019 Mar 19.

PMID:
30890578
13.

Non-insulin treatments for Type 1 diabetes: critical appraisal of the available evidence and insight into future directions.

Wright LA, Hirsch IB.

Diabet Med. 2019 Jun;36(6):665-678. doi: 10.1111/dme.13941. Epub 2019 Mar 27. Review.

PMID:
30801765
14.

Connecting the Dots: Validation of Time in Range Metrics With Microvascular Outcomes.

Hirsch IB, Sherr JL, Hood KK.

Diabetes Care. 2019 Mar;42(3):345-348. doi: 10.2337/dci18-0040. No abstract available.

PMID:
30787056
15.

Self-Monitoring of Blood Glucose.

Garg SK, Hirsch IB.

Diabetes Technol Ther. 2019 Feb;21(S1):S4-S12. doi: 10.1089/dia.2019.2501. No abstract available.

PMID:
30785324
16.

CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM - 2019 EXECUTIVE SUMMARY.

Garber AJ, Abrahamson MJ, Barzilay JI, Blonde L, Bloomgarden ZT, Bush MA, Dagogo-Jack S, DeFronzo RA, Einhorn D, Fonseca VA, Garber JR, Garvey WT, Grunberger G, Handelsman Y, Hirsch IB, Jellinger PS, McGill JB, Mechanick JI, Rosenblit PD, Umpierrez GE.

Endocr Pract. 2019 Jan;25(1):69-100. doi: 10.4158/CS-2018-0535. Erratum in: Endocr Pract. 2019 Feb;25(2):204.

PMID:
30742570
17.

Ranting in 2019: Are Things Improving?

Hirsch IB.

Diabetes Technol Ther. 2019 Feb;21(2):59-61. doi: 10.1089/dia.2019.0004. Epub 2019 Jan 23. No abstract available.

PMID:
30672716
18.

Clinical Implications of Real-time and Intermittently Scanned Continuous Glucose Monitoring.

Edelman SV, Argento NB, Pettus J, Hirsch IB.

Diabetes Care. 2018 Nov;41(11):2265-2274. doi: 10.2337/dc18-1150. Review.

PMID:
30348844
19.

Advances in Glucose Monitoring and Automated Insulin Delivery: Supplement to Endocrine Society Clinical Practice Guidelines.

Peters AL, Ahmann AJ, Hirsch IB, Raymond JK.

J Endocr Soc. 2018 Oct 5;2(11):1214-1225. doi: 10.1210/js.2018-00262. eCollection 2018 Nov 1.

20.

Brief Commentary: Confusing Treatment Guidelines for Patients With Type 2 Diabetes.

Hirsch IB, Skyler JS.

Ann Intern Med. 2018 Aug 21;169(4):253. doi: 10.7326/M18-1473. Epub 2018 Jun 26. No abstract available.

PMID:
29946704
21.

Availability and Affordability of Essential Medicines: Implications for Global Diabetes Treatment.

Beran D, Ewen M, Lipska K, Hirsch IB, Yudkin JS.

Curr Diab Rep. 2018 Jun 16;18(8):48. doi: 10.1007/s11892-018-1019-z. Review.

PMID:
29907884
22.

Erratum. Why Are We Failing to Address the Issue of Access to Insulin? A National and Global Perspective. Diabetes Care 2018;41:1125-1131.

Beran D, Hirsch IB, Yudkin JS.

Diabetes Care. 2018 Sep;41(9):2048. doi: 10.2337/dc18-er09a. Epub 2018 Jun 15. No abstract available.

23.

The Hybrid Closed-Loop System: Evolution and Practical Applications.

Weaver KW, Hirsch IB.

Diabetes Technol Ther. 2018 Jun;20(S2):S216-S223. doi: 10.1089/dia.2018.0091. Epub 2018 Jun 6.

PMID:
29873517
24.

Why Are We Failing to Address the Issue of Access to Insulin? A National and Global Perspective.

Beran D, Hirsch IB, Yudkin JS.

Diabetes Care. 2018 Jun;41(6):1125-1131. doi: 10.2337/dc17-2123. Erratum in: Diabetes Care. 2018 Jun 15;:.

PMID:
29784696
25.

Health Care Spending on Diabetes in the U.S., 1996-2013.

Squires E, Duber H, Campbell M, Cao J, Chapin A, Horst C, Li Z, Matyasz T, Reynolds A, Hirsch IB, Dieleman JL.

Diabetes Care. 2018 Jul;41(7):1423-1431. doi: 10.2337/dc17-1376. Epub 2018 May 10.

26.

Clinically significant cognitive impairment in older adults with type 1 diabetes.

Chaytor NS, Barbosa-Leiker C, Ryan CM, Germine LT, Hirsch IB, Weinstock RS.

J Diabetes Complications. 2019 Jan;33(1):91-97. doi: 10.1016/j.jdiacomp.2018.04.003. Epub 2018 Apr 14.

PMID:
29728302
27.

Does Time-in-Range Matter? Perspectives From People With Diabetes on the Success of Current Therapies and the Drivers of Improved Outcomes.

Runge AS, Kennedy L, Brown AS, Dove AE, Levine BJ, Koontz SP, Iyengar VS, Odeh SA, Close KL, Hirsch IB, Wood R.

Clin Diabetes. 2018 Apr;36(2):112-119. doi: 10.2337/cd17-0094.

28.

A Randomized Clinical Trial of the Effect of Continuous Glucose Monitoring on Nocturnal Hypoglycemia, Daytime Hypoglycemia, Glycemic Variability, and Hypoglycemia Confidence in Persons with Type 1 Diabetes Treated with Multiple Daily Insulin Injections (GOLD-3).

Ólafsdóttir AF, Polonsky W, Bolinder J, Hirsch IB, Dahlqvist S, Wedel H, Nyström T, Wijkman M, Schwarcz E, Hellman J, Heise T, Lind M.

Diabetes Technol Ther. 2018 Apr;20(4):274-284. doi: 10.1089/dia.2017.0363. Epub 2018 Apr 2.

29.

In Response to Carter and Heinemann: Insulin Concentration in Vials Randomly Purchased in Pharmacies in the United States: Considerable Loss in the Cold Supply Chain.

Petersen MP, Hirsch IB, Skyler JS, Ostlund RE, Cefalu WT.

J Diabetes Sci Technol. 2018 Jul;12(4):890-891. doi: 10.1177/1932296818761972. Epub 2018 Mar 16. No abstract available.

30.

Variables associated with HbA1c and weight reductions when adding liraglutide to multiple daily insulin injections in persons with type 2 diabetes (MDI Liraglutide trial 3).

Dahlqvist S, Ahlén E, Filipsson K, Gustafsson T, Hirsch IB, Tuomilehto J, Imberg H, Ahrén B, Attvall S, Lind M.

BMJ Open Diabetes Res Care. 2018 Feb 24;6(1):e000464. doi: 10.1136/bmjdrc-2017-000464. eCollection 2018.

31.

DIABETES MANAGEMENT "UP IN THE AIR": IT'S TIME FOR CONSENSUS.

Trikudanathan S, Hirsch IB.

Endocr Pract. 2018 Jun;24(6):599-601. doi: 10.4158/EP-2017-0258. Epub 2018 Mar 2. No abstract available.

PMID:
29498917
32.

ONE-YEAR TIME ANALYSIS IN AN ACADEMIC DIABETES CLINIC: QUANTIFYING OUR BURDEN.

Huynh P, Toulouse A, Hirsch IB.

Endocr Pract. 2018 May;24(5):489-491. doi: 10.4158/EP-2017-0267. Epub 2018 Mar 2. No abstract available.

PMID:
29498912
33.

Diabetic Kidney Disease: Is There a Role for Glycemic Variability?

Subramanian S, Hirsch IB.

Curr Diab Rep. 2018 Feb 15;18(3):13. doi: 10.1007/s11892-018-0979-3. Review.

PMID:
29450720
34.

Self-Monitoring of Blood Glucose.

Garg SK, Hirsch IB.

Diabetes Technol Ther. 2018 Feb;20(S1):S3-S12. doi: 10.1089/dia.2018.2501. Review. No abstract available.

PMID:
29437471
35.
36.

CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM - 2018 EXECUTIVE SUMMARY.

Garber AJ, Abrahamson MJ, Barzilay JI, Blonde L, Bloomgarden ZT, Bush MA, Dagogo-Jack S, DeFronzo RA, Einhorn D, Fonseca VA, Garber JR, Garvey WT, Grunberger G, Handelsman Y, Hirsch IB, Jellinger PS, McGill JB, Mechanick JI, Rosenblit PD, Umpierrez GE.

Endocr Pract. 2018 Jan;24(1):91-120. doi: 10.4158/CS-2017-0153. Epub 2018 Jan 17.

PMID:
29368965
37.

Ranting in 2018: Are We Making Progress?

Hirsch IB.

Diabetes Technol Ther. 2018 Feb;20(2):91-93. doi: 10.1089/dia.2018.0004. No abstract available.

PMID:
29355434
38.

A Practical Approach to Using Trend Arrows on the Dexcom G5 CGM System for the Management of Adults With Diabetes.

Aleppo G, Laffel LM, Ahmann AJ, Hirsch IB, Kruger DF, Peters A, Weinstock RS, Harris DR.

J Endocr Soc. 2017 Nov 20;1(12):1445-1460. doi: 10.1210/js.2017-00388. eCollection 2017 Dec 1.

39.

Clinical Diabetes Centers of Excellence: A Model for Future Adult Diabetes Care.

Draznin B, Kahn PA, Wagner N, Hirsch IB, Korytkowski M, Harlan DM, McDonnell ME, Gabbay RA.

J Clin Endocrinol Metab. 2018 Mar 1;103(3):809-812. doi: 10.1210/jc.2017-02388.

PMID:
29309595
40.

Application of Glycemic Variability Percentage: Implications for Continuous Glucose Monitor Utilization and Analysis of Artificial Pancreas Data.

Garcia A, Balo AK, Buckingham BA, Hirsch IB, Peyser TA.

Diabetes Technol Ther. 2017 Dec;19(12):699-706. doi: 10.1089/dia.2017.0188.

PMID:
29243959
41.

Glycemic Variability Percentage: A Novel Method for Assessing Glycemic Variability from Continuous Glucose Monitor Data.

Peyser TA, Balo AK, Buckingham BA, Hirsch IB, Garcia A.

Diabetes Technol Ther. 2018 Jan;20(1):6-16. doi: 10.1089/dia.2017.0187. Epub 2017 Dec 11.

42.

AACE/ACE POSITION STATEMENT ON THE USE OF FOLLOW-ON BIOLOGICS AND BIOSIMILARS FOR ENDOCRINE DISEASES.

Fonseca VA, Bloomgarden ZT, Dagogo-Jack S, Grunberger G, Einhorn D, Garber AJ, Handelsman Y, Hirsch IB, Umpierrez GE.

Endocr Pract. 2017 Nov;23(11):1345-1349. doi: 10.4158/EP-2017-0052.

PMID:
29190135
43.

Impact of the 2013 National Rollout of CMS Competitive Bidding Program: The Disruption Continues.

Puckrein GA, Hirsch IB, Parkin CG, Taylor BT, Xu L, Marrero DG.

Diabetes Care. 2018 May;41(5):949-955. doi: 10.2337/dc17-0960. Epub 2017 Nov 17.

PMID:
29150529
44.

Diabetes and CKD in the United States Population, 2009-2014.

Zelnick LR, Weiss NS, Kestenbaum BR, Robinson-Cohen C, Heagerty PJ, Tuttle K, Hall YN, Hirsch IB, de Boer IH.

Clin J Am Soc Nephrol. 2017 Dec 7;12(12):1984-1990. doi: 10.2215/CJN.03700417. Epub 2017 Oct 20.

45.

Type 1 Diabetes in the Hospital: What Do We Know About Glucose Control?

Hirsch IB.

Diabetes Technol Ther. 2017 Oct;19(10):555-556. doi: 10.1089/dia.2017.0336. No abstract available.

PMID:
29045171
46.

Professional flash continuous glucose monitoring as a supplement to A1C in primary care.

Hirsch IB.

Postgrad Med. 2017 Nov;129(8):781-790. doi: 10.1080/00325481.2017.1383137. Epub 2017 Oct 5. Review.

PMID:
28945141
47.

PROFESSIONAL FLASH CONTINUOUS GLUCOSE MONITORING WITH AMBULATORY GLUCOSE PROFILE REPORTING TO SUPPLEMENT A1C: RATIONALE AND PRACTICAL IMPLEMENTATION.

Hirsch IB, Verderese CA.

Endocr Pract. 2017 Nov;23(11):1333-1344. doi: 10.4158/EP171962.RA. Epub 2017 Aug 17. Review.

PMID:
28816535
48.

Serum cystatin C in youth with diabetes: The SEARCH for diabetes in youth study.

Kanakatti Shankar R, Dolan LM, Isom S, Saydah S, Maahs DM, Dabelea D, Reynolds K, Hirsch IB, Rodriguez BL, Mayer-Davis EJ, Marcovina S, D'Agostino R Jr, Mauer M, Mottl AK.

Diabetes Res Clin Pract. 2017 Aug;130:258-265. doi: 10.1016/j.diabres.2017.06.010. Epub 2017 Jun 12.

49.

Human Insulin for Type 2 Diabetes: An Effective, Less-Expensive Option.

Lipska KJ, Hirsch IB, Riddle MC.

JAMA. 2017 Jul 4;318(1):23-24. doi: 10.1001/jama.2017.6939. No abstract available.

PMID:
28604935
50.

A Simple Composite Metric for the Assessment of Glycemic Status from Continuous Glucose Monitoring Data: Implications for Clinical Practice and the Artificial Pancreas.

Hirsch IB, Balo AK, Sayer K, Garcia A, Buckingham BA, Peyser TA.

Diabetes Technol Ther. 2017 Jun;19(S3):S38-S48. doi: 10.1089/dia.2017.0080.

Supplemental Content

Loading ...
Support Center